Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

5.27
-0.2200-4.01%
Pre-market: 5.24-0.0300-0.57%04:05 EDT
Volume:1.35M
Turnover:7.12M
Market Cap:101.93M
PE:-0.87
High:5.80
Open:5.80
Low:5.13
Close:5.49
52wk High:20.56
52wk Low:5.13
Shares:19.34M
Float Shares:13.25M
Volume Ratio:1.54
T/O Rate:10.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.00
PE(LYR):-0.89

Loading ...

Corbus Pharma director Anne Altmeyer disposes of 2,412 shares worth $19,085.82

Reuters
·
Jun 12

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Jun 10

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Jun 06

Corbus Pharmaceuticals Holdings Inc. Stock Climbs 8.5%, Outperforms Peers

Dow Jones
·
Jun 05

Top Corbus Pharmaceuticals Executive Quietly Makes a Bold Insider Move

TIPRANKS
·
Jun 04

Corbus Chief Business Officer Nishant Saxena acquires $101,115 of common shares

Reuters
·
Jun 04

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 03

Corbus Pharmaceuticals (CRBP) Gets a Buy from Guggenheim

TIPRANKS
·
Jun 02

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 02

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Jasper Therapeutics (JSPR) and Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
Jun 02

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 30

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
May 28

Wedbush Sticks to Their Buy Rating for Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
May 27

Corbus Pharmaceuticals Holdings Inc : Wedbush Cuts Target Price to $30 From $38

THOMSON REUTERS
·
May 27

Corbus Pharmaceuticals Holdings Inc. Stock Slides 30.3%, Underperforms Peers

Dow Jones
·
May 27

Corbus Pharmaceuticals Falls on Reports of Adverse Events in Tumor-Treatment Study

Dow Jones
·
May 27

Corbus Pharmaceuticals share selloff overdone, says Guggenheim

TIPRANKS
·
May 27

Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Corbus Pharmaceuticals (CRBP)

TIPRANKS
·
May 27

Corbus Pharmaceuticals Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
May 27

Corbus reports 42.9% response rate for CRB-701 in Phase 1/2 second-line oropharyngeal cancer study

Reuters
·
May 26